Arisha Ishtiaq Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Researcher

University of Arkansas at Little Rock

unknown

2 h-index 3 pubs 13 cited

Research Areas

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Arisha Ishtiaq's research focuses on the development of nanomedicines for cancer therapy, specifically investigating their potential in combined chemo-phototherapy and photodynamic therapy.

Her work has explored the use of doxorubicin-based and cationic porphyrin-based ionic nanomedicines. These studies aim to enhance the effectiveness of existing cancer treatment modalities. Ishtiaq has published three papers in this area, with her h-index at 2 and total citations at 13. She has collaborated with several researchers at the University of Arkansas at Little Rock, including Noureen Siraj, Mujeebat Bashiru, Mavis Forson, and Nawab Ali, co-authoring three publications with each.

Ishtiaq's recent publications include "Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer" (2024) and "IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS" (2024). She also contributed to "Cationic Porphyrin-Based Ionic Nanomedicines for Improved Photodynamic Therapy" (2023). Her recent activity indicates ongoing engagement in research.

Metrics

h-index: 2
Publications: 3
Citations: 13

Selected Publications

IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS (2024) DOI
Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer (2024) DOI
Cationic Porphyrin-Based Ionic Nanomedicines for Improved Photodynamic Therapy (2023) DOI